BIOMIMESYS plates are suitable for iPSC-differentiation. However, if the differentiation protocol was designed from 2D experiments, an adaptation of the growth factors’ concentrations might be necessary. As an example, in our hands the differentiation of iPSCs into hepatocytes is better in BIOMIMESYS Liver than in 2D, with a much more mature phenotype.
Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.